Pregabid 50 mg (Capsule)
Unit Price: ৳ 16.80 (3 x 10: ৳ 504.00)
Strip Price: ৳ 168.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Albion laboratories limited |
| Also available as |
Title
- Pregabid 50 mg Capsule
Categories
- Medicine
- Anticonvulsant
- Analgesic
- Neurological Disorder Treatment
- Seizure Management
Dosage
- Maximum recommended dose of 100 mg three times a day
- Dosing should begin at 50 mg three times a day
- Recommended doses of 75 to 150 mg two times a day
- Recommended dose of 300 to 450 mg/day for fibromyalgia
- Recommended dose range of 150 to 600 mg/day for spinal cord injury
Route of Administration
- Oral route
- Can be taken with or without food
- Pregabalin CR tablet should be administered after an evening meal
- Should be swallowed whole and not split, crushed, or chewed
Pharmacology
- Structural derivative of GABA
- Binds with high affinity to alpha2-delta site in central nervous system tissues
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Contraindications
- Known hypersensitivity to Pregabalin or its components
Side Effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Difficulty with concentration/attention
- Increased weight and increased appetite in pediatric patients
Precautions & Warnings
- Possible angioedema
- Potential hypersensitivity reactions
- Increased risk of suicidal thoughts or behavior
- Potential respiratory depression
- May cause dizziness and impair ability to drive or operate machinery
- Caution with concomitant CNS depressants
- May cause peripheral edema
- Caution when coadministering with thiazolidinedione antidiabetic agents
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Potential risk to a fetus
- Small amounts detected in the milk of lactating women
- Breastfeeding not recommended
Use in Special Populations
- Safety and effectiveness not established in pediatric patients for various conditions
- Safety and effectiveness not established in pediatric patients for Pregabid extended-release tablet
Overdose Effects
- Signs and symptoms include reduced consciousness, depression/anxiety, confusional state, agitation, restlessness, seizures, and heart block
- No specific antidote
Drug Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C8H17NO2
Common Questions
- First-line treatment for neurotic pain, shingles, seizures, and fibromyalgia
- Duration of use depends on condition and improvement
- Dosage should be taken as prescribed by doctor
- Should be taken after food in prescribed dosage
- Storage and disposal instructions
- Works differently for different diseases